OCRL
Inositol polyphosphate 5-phosphatase OCRL
Also known as: Dent-2, OCRL_HUMAN, OCRL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01968
- Gene
- OCRL
- Ensembl
- ENSG00000122126
- Chromosome
- X
- Canonical length
- 901 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Microtubules,Primary cilium,Centriolar satellite,Basal body,Cytosol
OverviewNCBI Gene
This gene encodes an inositol polyphosphate 5-phosphatase. This protein is involved in regulating membrane trafficking and is located in numerous subcellular locations including the trans-Golgi network, clathrin-coated vesicles and, endosomes and the plasma membrane. This protein may also play a role in primary cilium formation. Mutations in this gene cause oculocerebrorenal syndrome of Lowe and also Dent disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
901 residues, UniProt reviewed canonical sequence.
>Q01968|OCRL
1 MEPPLPVGAQ PLATVEGMEM KGPLREPCAL TLAQRNGQYE LIIQLHEKEQ HVQDIIPINS
61 HFRCVQEAEE TLLIDIASNS GCKIRVQGDW IRERRFEIPD EEHCLKFLSA VLAAQKAQSQ
121 LLVPEQKDSS SWYQKLDTKD KPSVFSGLLG FEDNFSSMNL DKKINSQNQP TGIHREPPPP
181 PFSVNKMLPR EKEASNKEQP KVTNTMRKLF VPNTQSGQRE GLIKHILAKR EKEYVNIQTF
241 RFFVGTWNVN GQSPDSGLEP WLNCDPNPPD IYCIGFQELD LSTEAFFYFE SVKEQEWSMA
301 VERGLHSKAK YKKVQLVRLV GMMLLIFARK DQCRYIRDIA TETVGTGIMG KMGNKGGVAV
361 RFVFHNTTFC IVNSHLAAHV EDFERRNQDY KDICARMSFV VPNQTLPQLN IMKHEVVIWL
421 GDLNYRLCMP DANEVKSLIN KKDLQRLLKF DQLNIQRTQK KAFVDFNEGE IKFIPTYKYD
481 SKTDRWDSSG KCRVPAWCDR ILWRGTNVNQ LNYRSHMELK TSDHKPVSAL FHIGVKVVDE
541 RRYRKVFEDS VRIMDRMEND FLPSLELSRR EFVFENVKFR QLQKEKFQIS NNGQVPCHFS
601 FIPKLNDSQY CKPWLRAEPF EGYLEPNETV DISLDVYVSK DSVTILNSGE DKIEDILVLH
661 LDRGKDYFLT ISGNYLPSCF GTSLEALCRM KRPIREVPVT KLIDLEEDSF LEKEKSLLQM
721 VPLDEGASER PLQVPKEIWL LVDHLFKYAC HQEDLFQTPG MQEELQQIID CLDTSIPETI
781 PGSNHSVAEA LLIFLEALPE PVICYELYQR CLDSAYDPRI CRQVISQLPR CHRNVFRYLM
841 AFLRELLKFS EYNSVNANMI ATLFTSLLLR PPPNLMARQT PSDRQRAIQF LLGFLLGSEE
901 DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OCRL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 35 nTPM
- choroid plexus: 28 nTPM
- ovary: 24 nTPM
- seminal vesicle: 22 nTPM
- testis: 22 nTPM
- urinary bladder: 21 nTPM
Single-cell type
- choroid plexus epithelial cells: 97 nCPM
- sertoli cells: 89 nCPM
- retinal pigment epithelial cells: 55 nCPM
- thyrotrophs: 54 nCPM
- adrenal medulla cells: 53 nCPM
- peritubular myoid cells: 52 nCPM
Immune cell
- non-classical monocyte: 3.7 nTPM
- myeloid DC: 1.2 nTPM
- intermediate monocyte: 1.1 nTPM
- classical monocyte: 1 nTPM
- plasmacytoid DC: 0.4 nTPM
- total PBMC: 0.4 nTPM
Brain region
- choroid plexus: 64 nTPM
- hypothalamus: 47 nTPM
- pons: 42 nTPM
- midbrain: 34 nTPM
- cerebral cortex: 33 nTPM
- thalamus: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OCRL.
Disease | AllUniProt
Conditions OCRL is implicated in, by any mechanism.
- Lowe oculocerebrorenal syndrome (OCRL) MIM:309000
- Dent disease 2 (DENT2) MIM:300555
Disease | GeneticClinVar
149 pathogenic / likely-pathogenic of 1,068 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Lowe syndrome
- Dent disease type 2
- Thyroid cancer, nonmedullary, 1
- OCRL-related disorder
- Nephrolithiasis/nephrocalcinosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.96
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- in utero embryonic development
- inositol phosphate metabolic process
- lipid metabolic process
- membrane organization
- phosphatidylinositol biosynthetic process
- phosphatidylinositol dephosphorylation
- signal transduction
Molecular functions
- GTPase activator activity
- inositol phosphate phosphatase activity
- inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity
- inositol-1,4,5-trisphosphate 5-phosphatase activity
- phosphatidylinositol phosphate 4-phosphatase activity
- phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity
- phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity
- phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
- small GTPase binding
Cellular components
- centriolar satellite
- ciliary basal body
- cilium
- clathrin-coated pit
- clathrin-coated vesicle
- cytoplasm
- cytosol
- early endosome
- early endosome membrane
- Golgi stack
- Golgi-associated vesicle
- lysosome
- membrane
- microtubule cytoskeleton
- neuron projection
- nucleus
- phagocytic vesicle membrane
- photoreceptor outer segment
- plasma membrane
- trans-Golgi network
Protein domainsUniProt · Pfam · InterPro
- Rho GTPase-activating protein domain
- Inositol polyphosphate-related phosphatase
- Rho GTPase activation protein
- Immunoglobulin-like fold
- Endonuclease/exonuclease/phosphatase superfamily
- OCRL1/INPP5B, INPP5c domain
- Inositol 5-phosphatase
- Inositol polyphosphate 5-phosphatase OCRL, RhoGAP
- OCRL-1/2, ASH domain
- RhoGAP domain
- Inositol polyphosphate 5-phosphatase OCRL-like, ASH domain
- Endonuclease/Exonuclease/phosphatase family 2
- Inositol polyphosphate 5-phosphatase, clathrin binding domain
- OCRL1, PH domain
- Inositol polyphosphate 5-phosphatase clathrin binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OCRL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OCRL as an antibody target. Whether an autoantibody or antibody against OCRL could matter depends on whether native OCRL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OCRL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OCRL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...